Cargando…
The involving progress of MSCs based therapy in atherosclerosis
Atherosclerosis is a chronic progressive vascular inflammation characterized by lipid deposition and plaque formation, for which vascular cell dysfunction and impaired immune responses are involved. Up to now, lipid-lowering drugs remain the main therapy for treating atherosclerosis; however, the su...
Autores principales: | Lin, Ying, Zhu, Wei, Chen, Xiaomin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275513/ https://www.ncbi.nlm.nih.gov/pubmed/32503682 http://dx.doi.org/10.1186/s13287-020-01728-1 |
Ejemplares similares
-
The role of MSCs and CAR-MSCs in cellular immunotherapy
por: Yan, Lun, et al.
Publicado: (2023) -
TA-MSCs, TA-MSCs-EVs, MIF: their crosstalk in immunosuppressive tumor microenvironment
por: Zhang, Zhenghou, et al.
Publicado: (2022) -
The promising approach of MSCs therapy for COVID-19 treatment
por: Samanipour, Reza, et al.
Publicado: (2022) -
Macrophage-Based Therapies for Atherosclerosis Management
por: Peng, Renyi, et al.
Publicado: (2020) -
Research progress on Mesenchymal Stem Cells (MSCs), Adipose-Derived Mesenchymal Stem Cells (AD-MSCs), Drugs, and Vaccines in Inhibiting COVID-19 Disease
por: Gentile, Pietro, et al.
Publicado: (2020)